COI.
search Request for Consideration arrow_forward menu
close Submit Innovation
close
92
New Jersey, USA / Tel Aviv, Israel Private / Revenue-Funded

Visualizing mRNA Translation in Cells

Anima Biotech • Led by ["Yochi Slonim"]

🔒 Confidential
COI SCORE 92 VERIFIED

🔬 The Innovation Core

The Pain Point

Many diseases are caused by proteins that are hard to block once they are made. It is often better to stop the protein from being created (translated) in the first place, but visualizing this process in real-time is incredibly difficult.

The Solution

The 'mRNA Lightning' platform. It tags tRNA (the movers of protein synthesis) with light, allowing their AI to 'watch' proteins being born in live cells. They then screen for small molecules that specifically slow down or stop the production of disease-causing proteins.

⚡ Verified Impact

● Validated
CERTIFICATION

Prototype

TRL 6/9

📊 Market Traction

Revenue History ($M)

Market Share

🧠 Analyst Verdict: Capital Efficient Innovator

"Anima is an outlier: it raised very little VC money ($11M) but funded its growth through massive pharma checks (AbbVie, Takeda, Lilly). This 'non-dilutive' growth strategy is rare and validates their unique tech platform which visualizes biology that others cannot see."

✅ Pros

  • ["Capital Efficiency: Retained high founder equity by funding via partnerships instead of VC.","Visual Data Moat: Proprietary imaging data of protein synthesis is unique in the industry.","Broad Applicability: Can target 'undruggable' proteins by stopping their synthesis upstream."]

⚠️ Risks

  • ["Platform Risk: Relies heavily on the 'phenotypic screening' approach which can be harder to de-convolute than target-based design.","Partner Dependency: Revenue is lumpy and dependent on achieving milestones for big pharma partners."]

🛠️ Use Cases

Market Maturity

Stop Guessing.
Know What's Deployable.

Marketing brochures look the same for TRL-3 (Concept) and TRL-9 (Proven) tech. Our radar cuts through the noise, showing you exactly if this innovation has crossed the "Pilot-to-Production" chasm.

9

Commercial Grade

Fully audited operational history. Ready for scale.

6

Prototype / Pilot

Functional in relevant environments. High risk, high reward.

Current Maturity Status

TRL Score 6.0 / 9.0
  • check_circle Technology validated in lab (TRL 4)
  • check_circle System prototype demonstration (TRL 7)
  • pending Operational Verification (In Progress)
Transparency

Forensic Evidence Chain

We don't just "approve" listings. We build a permanent, immutable audit trail for every verified claim. See exactly what was checked, when, and by whom.

View Sample Audit Report →

Technical Diligence

> Architecture Review: PASS
> Security Audit: ISO 27001
> Scalability Test: 10k TPS

Customer Verification

> Client Interview: #8821
> Deployment Status: LIVE
> ROI Confirmed: 18% Savings

Certification Issued

STATUS: VERIFIED verified

Enterprise Action Center

Select the engagement model that fits your business needs.

🚀
Launch Pilot / POC
Submit your problem statement and request a proof of concept scope.
💡
Propose Use Case
Have a new application for this tech? Submit a use case for review.
⭐
Submit Review
Already using this solution? Verify impact and submit your CSAT score.
🛡️
Request Due Diligence
Access compliance certs, security audits, and financial health reports.

Secure Premium Access

Complete to proceed with your request